Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
NCT05663502 · View on ClinicalTrials.gov ↗
Study Summary
This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors related to HIV and cancers that occur commonly in people living with HIV.
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
Study Locations (8)
California
- UC San Diego Moores Cancer Center — La Jolla
- University of California, San Francisco — San Francisco
New York
- Mount Sinai Hospital — New York
- Memorial Sloan Kettering Cancer Center — New York
District of Columbia
- George Washington University — Washington D.C.
Florida
- University of Miami — Miami
Maryland
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore
Utah
- Huntsman Cancer Institute, University of Utah — Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2035-08-31 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05663502
The ClinicalTrials.gov registry entry for NCT05663502 describes a study currently listed as recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 11 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 10 conditions, with Lymphoma appearing as the primary indexed condition, and to 1 intervention — of which Biospecimen Collection is the first listed. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT05663502 reports 8 study locations spanning 6 distinct geographic areas — top geographies include California, New York, District of Columbia. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT05663502 about?
NCT05663502 is a clinical study titled "Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers". This study collects blood and tissue samples for research of human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS)-related cancers. Collecting blood and tissue samples and studying biomarkers in the laboratory may help doctors to learn how are biologic or genetic factors relat...
What is the current status of trial NCT05663502?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2023-05-10. Estimated completion is 2035-08-31.
What conditions does trial NCT05663502 study?
This clinical trial studies the following conditions: Lymphoma, Malignant Solid Neoplasm, Hematopoietic and Lymphoid Cell Neoplasm, HIV Infection, Kaposi Sarcoma. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
What interventions are being tested in trial NCT05663502?
The interventions under investigation include: Biospecimen Collection (PROCEDURE). Each intervention is being evaluated for safety and efficacy as part of this clinical study.
Who is sponsoring clinical trial NCT05663502?
This trial is sponsored by AIDS Malignancy Consortium, which has 11 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT05663502 being conducted?
This trial has 8 study locations across California, District of Columbia, Florida, Maryland, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.